Healthy adults
Conditions
Interventions
Two capsules of GBE/MST supplement, once a day for 24 weeks
Two capsules of GBE supplement, once a day for 24 weeks
Two capsules of placebo, once a day for 24 weeks
Sponsors
Department of Aging Research and Geriatric Medicine IDAC, Tohoku University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Healthy adults who is confirmed with a written informed consent. Normal cognitive function at baseline is confirmed by Montreal Cognitive Assessment battery Japanese version (more than 26).
Exclusion criteria
Exclusion criteria: 1) With past history of severe neurological diseases. 2) With critical bleeding incidents. 3) Use of antithrombotic medicine. 4) Severe depression 5) Patients with diabetes mellitus. 6) With severe visual or auditory disability. 7) Individuals with any metal implantation, such as cardiac pacemaker, coronary stent and artificial joint. 8) Claustrophobia. 9) Use of any supplement. 10) Creatinine clearance less than 15ml/min. 11) Patients with gastrointestinal diseases or metabolic diseases. 12) Diagnosed psychiatric disorders. 13) Participants who cannot obtain the informed consent. 14) Allergy to the study materials. 15) Individuals who is not suitable for participating in this study decided by principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint of this study is to discover any alteration of cognitive function in healthy adults assessed by Wechsler Memory Scale revised (WMS-R) following 24 weeks administration of GBE/MST. | — |
Countries
Japan
Contacts
Public ContactTaizen Nakase
IDAC, Tohoku University Department of Aging Research and Geriatric Medicine
Outcome results
None listed